Bevacizumab-induced proteinuria and its association with antihypertensive drugs: A retrospective cohort study using a Japanese administrative database

Proteinuria is a major side-effect of the anti-tumor drug bevacizumab, although its incidence and risk factors in the real world are still unclear. Although renin-angiotensin-aldosterone system inhibitors are used clinically to prevent proteinuria, their efficacy remains unclear. The aim of the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiyomi, Anna, Koizumi, Fukiko, Imai, Shinobu, Yamana, Hayato, Horiguchi, Hiromasa, Fushimi, Kiyohide, Sugiura, Munetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414654/
https://www.ncbi.nlm.nih.gov/pubmed/37561756
http://dx.doi.org/10.1371/journal.pone.0289950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414654/
https://www.ncbi.nlm.nih.gov/pubmed/37561756
http://dx.doi.org/10.1371/journal.pone.0289950

Ejemplares similares